Citations 1
SWOG 1211: A randomized phase I/II study of optimal induction therapy for newly diagnosed high-risk multiple myeloma (HRMM).
Usmani, Saad Zafar, Hoering, Antje , Sexton, Rachel , Shah, Jatin J., Fredette, Sandi, Durie, Brian G.M. , Zonder, Jeffrey A. , Dhodapkar, Madhav V. , Mahindra, Anuj, Zimmerman, Todd M., Richardson, Paul G. , Usmani, Saad Zafar, Ailawadhi, Sikander , Rajkumar, S. Vincent , Richardson, Paul Gerard Guy , Orlowski, Robert Z.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS8624-TPS8624
